We, therefore, hypothesized that EZH2 inhibition by GSK126 renders DMG glioma cells dependent on cholesterol biosynthesis, thus giving the possibility to explore statins or other lipid reducing drugs as treatment option in this pathology. This evidence concerns the gene EZH2 and central nervous system cancer.